Psychosomatic and Education Research Center, Oral Oncology Center, São Paulo State University (Unesp), School of Dentistry, Araçatuba, São Paulo, Brazil.
Cancer Res. 2021 Oct 15;81(20):5144-5146. doi: 10.1158/0008-5472.CAN-21-3077.
Catecholamines, which are involved in response to physical or emotional stress, have emerged as one of the main mediators of the relationship between chronic stress and cancer progression. The study in this issue of by Liu and colleagues reveals a new mechanism by which psychologic stress stimulates cancer progression through the D2 dopamine receptor and activation of the oxygen-independent HIF1α pathway. Although most investigations so far have focused on the action of the stress-related catecholamines norepinephrine and epinephrine on tumor cells, this study shows that dopamine and its receptor can be a potential therapeutic target. The findings broaden the understanding of the interaction of catecholamines with the tumor microenvironment and reinforces the need to look at psychologic stress as a modulator of cancer progression..
儿茶酚胺参与对身体或情绪压力的反应,已成为慢性压力与癌症进展之间关系的主要介质之一。刘及其同事在本期杂志中的研究揭示了一种新的机制,即心理压力通过 D2 多巴胺受体和激活氧非依赖性 HIF1α 途径刺激癌症进展。尽管迄今为止大多数研究都集中在与应激相关的儿茶酚胺去甲肾上腺素和肾上腺素对肿瘤细胞的作用上,但这项研究表明多巴胺及其受体可能是一个潜在的治疗靶点。这些发现拓宽了对儿茶酚胺与肿瘤微环境相互作用的理解,并强化了将心理压力视为癌症进展调节剂的必要性。